Lazard Asset Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,155
| Closed | -$40K | – | 2487 |
|
|
2024
Q4 | $40K | Hold |
2,155
| – | – | ﹤0.01% | 2016 |
|
|
2024
Q3 | $48K | Sell |
2,155
-2,563
| -54% | -$57.1K | ﹤0.01% | 1928 |
|
|
2024
Q2 | $98K | Buy |
+4,718
| New | +$98K | ﹤0.01% | 1757 |
|
|
2023
Q4 | – | Sell |
-5,674
| Closed | -$44K | – | 2403 |
|
|
2023
Q3 | $44K | Sell |
5,674
-2,986
| -34% | -$23.2K | ﹤0.01% | 1894 |
|
|
2023
Q2 | $86K | Buy |
8,660
+5,781
| +201% | +$57.4K | ﹤0.01% | 1638 |
|
|
2023
Q1 | $25K | Buy |
2,879
+1,779
| +162% | +$15.4K | ﹤0.01% | 2003 |
|
|
2022
Q4 | $11K | Buy |
+1,100
| New | +$11K | ﹤0.01% | 2191 |
|